Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 31Stomach Neoplasms 4Neoplasms 4Cardiotoxicity 4Neoplasm Metastasis 3Brain Neoplasms 2Neurotoxicity Syndromes 1Neoplasms, Second Primary 1Neoplasm, Residual 1HER2-positive Breast Cancer 1HER2+ Breast Cancer 1Feasibility 1Fatigue 1Breast Cancer Organoids 1

Interventions

pertuzumab 1Vemurafenib 1Trastuzumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Feasibility × Trastuzumab × Clear all
NCT05177666 2022-01-04

a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors

The University of Hong Kong-Shenzhen Hospital

Unknown
120 enrolled

Feasibility

Data powered by HemOnc (CC BY 4.0) Colophon âš¡